Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Persistently Seeking Stroke Solutions

This article was originally published in Start Up

Executive Summary

Even as ischemic stroke researchers debate what went wrong following a string of high-profile, expensive clinical trial failures, they're optimistic that advances in understanding of the disease and application of lessons learned from past mistakes will yield more effective therapies.

Related Content

CoAxia's New Path in Stroke
Window of Opportunity Opens in Stroke
Concentric Medical: Breaking the Stroke Device Barrier
Small Steps Forward in Treating Ischemic Stroke
CoAxia Inc.
Interventional Neuroradiology's Growing Pains
A Little Light Shines On Interventional Neuroradiologists
Stroke Prevention: The Newest Frontier in Interventional Cardiology
The Tantalizing Market for Stroke Devices
Going Gangbusters on Stroke


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts